MD, PhD, MAE, FMedSci, FRCP, FRCPEd.

fraud

I came across an interesting paper entitled “The Ethics of Tawas and Other Rituals in Medical Practices“. Here is its abstract:

Rituals in medical practice have either been seen as an anthropological aspect of current biomedical processes or as a pre-scientific aspect of complementary and alternative medicine (CAM). In either tendency, the literature has since failed to account for these rituals as rituals—conveyors of meaning, expressions of identity, and even as a rite of passage from illness to wellness. As an alternative to current discussions, this paper presents the case study of tawas, a diagnostic ritual from Philippine traditional medicine that determines personalistic and mystical causes of illnesses. As a non-intrusive procedure, tawas involves incantations and some ritual objects, e.g., rice, candle, axe, etc., that do not pose any direct harm nor benefit to the patient. While complete reliance on tawas at the expense of proper medical procedures could harm patients, the very ritual of tawas itself occupies a limbo within non-beneficence and non-maleficence. Following a Wittgensteinian perspective of treating rituals as meaning-laden human activities, this paper argues that rituals like tawas, much like other rituals embedded in biomedical practices, should be understood as rituals and not as empirical cures, thereby allowing their tolerance in medical practice in general.

The author seems to advocate for the cultural integration of traditional practices like tawas into a broader medical framework. They categorize tawas not as a physiological intervention, but define it as a conveyor of meaning.  By addressing the “meaning-laden” aspect of illness, the ritual may address the psychological and social dimensions of a patient’s health, even if it has no effect on their physical pathology.

It is claimed that, since tawas involves non-intrusive objects (candles, rice), it is physically benign. At the same time it is acknowledged that “complete reliance” on tawas could harm patients. From a clinical safety standpoint, the “limbo” is only maintained if the ritual is strictly adjunctive rather than alternative.

The text uses a Wittgensteinian perspective, focusing on rituals as expressions rather than theories. Modern neuroscience suggests that the “ritual” of care—the white coat, the focused attention, the diagnostic process—triggers real neurobiological changes (e.g., dopamine and endorphin release). Aacknowledging the symbolic healing power that rituals have on patient anxiety and the “meaning response,” which can objectively improve health outcomes by reducing cortisol and stress.

The author identifies tawas as a diagnostic ritual which might well be the most contentious point. In science, a “diagnosis” must be reliable and valid. Tawas clearly fails the scientific criteria for validity. The author’s defence is that tawas shouldn’t be judged by those criteria at all. While this might be philosophically sound, in a clinical setting, a “mystical diagnosis” must conflict with a biological one, potentially leading to patient non-compliance with life-saving treatments.

I remember it well: when I was a kid, I went every day in the evening to a nearby farm to fetch a litre of luke warm raw milk. I was lucky; I never caught tuberculosis or any other infection that is transmitted in this way.

Today, raw milk has become the centrepiece of a heated debate. Once only on rural homesteads, unpasteurized milk is now being championed by a powerful coalition of political figures like Robert F. Kennedy Jr., promoters of so-called alternative medicine (SCAM), and “trad wife” influencers. This movement frames raw milk as a “magical health secret” suppressed by a corrupt establishment. However, beneath the veneer of “food freedom” and nostalgic aesthetics lies a complex interplay of populism, nutritional misinformation, outright BS, and significant public health risks.

The issue is largely fuelled by RFK Jr. and his “Make America Healthy Again” (MAHA) idiocy. For him, raw milk is less of a dietary preference and more of a symbol of resistance against federal overreach. He frequently characterizes the FDA’s restrictions on raw milk as a “war on farmers” and an example of “regulatory capture.” In his worm-eaten mind, federal agencies are not protecting the public from pathogens but are instead protecting the profits of “Big Dairy” by criminalising traditional foodways. By pushing for the legalisation of raw milk, Kennedy taps into a deep-seated distrust of institutions that has intensified in the post-pandemic US. He frames the choice to drink unpasteurized milk as a fundamental civil liberty, positioning himself as a defender of the individual against a nasty “nanny state.”

Simultaneously, the “trad wife” and SCAM movements are providing the lifestyle framework for raw milk promotion. On social media, influencers portray a return to traditional domesticity, featuring sourdough starters, hand-churned butter, and glass jars of creamy, raw milk. In this context, raw milk provides a “moral signal” for those who have little else to worry about. What counts is the willingness to go to great lengths to bypass industrial food systems and provide “pure” and “natural” nourishment for the whole family – because pasteurisation “kills” the milk, destroying vital enzymes and probiotics that could cure everything from asthma to lactose intolerance.

As soon as these claims are held up to scientific scrutiny, the “magic” begins to dissipate. The core argument – namely that raw milk is nutritionally superior – is largely unsupported by sound evidence. Modern pasteurisation is as non-invasive as possible. While heat slightly reduces levels of Vitamin C, milk is not a primary source of that vitamin anyway. Moreover, the levels of protein, calcium, and essential minerals remain virtually identical to the raw product. Furthermore, the valuable “enzymes” touted by advocates are enzymes that the human stomach acid neutralizes before they can be absorbed.

On top of all this, there is potential for serious harm. The most dangerous aspect of the raw milk nonsense is the dismissal of microbial risk. Before pasteurisation became standard in the early 20th century, milk was a leading cause of tuberculosis, typhoid, and scarlet fever. Today, even on the most meticulously managed farms, cows can naturally shed E. coli, Salmonella, and Listeria and contamination can occur in a split second during the milking process. The rise of the H5N1 (Bird Flu) virus in dairy cattle in recent years has added a lethal new variable; while pasteurisation effectively inactivates the virus, raw milk remains a potential vector for human infection. A recent study showed, for instance, that unpasteurized milk, consumed by only 3.2% of the population, and cheese, consumed by only 1.6% of the population, caused 96% of illnesses caused by contaminated dairy products.

So, the current raw milk frenzy puts a spotlight on the ignorance of those who support it. While raw milk is marketed as a health-conscious return to nature, it is primarily a brainless and unnecessary revival of long-forgotten risks. Pasteurization is – after immunisation (that is also rejected by these clowns) – one the most successful public health interventions in history. Advocates are not just embracing “food freedom”; they are embracing a level of risk that modern medicine spent a century eliminating.

 

The US “Health Freedom Movement” (HFM) is a coalition of activists, alternative practitioners, supplement and device manufacturers, and libertarian or populist politicians who oppose strong government regulation of healthcare. They claim to defend the individual’s right to choose any treatment or product they consider beneficial, especially so-called alternative medicine (SCAM).

Its roots lie in resistance to medical licensing and in movements around homeopathy, naturopathy, and chiropractic, which often portrayed organized medicine as a cartel limiting patient choice. The John Birch Society and other conservative groups use the term to oppose fluoridation, vaccination mandates, and federal health programs. During 1990s–2000s, the Dietary Supplement Health and Education Act (DSHEA) of 1994, backed by a coalition of supplement companies and “health freedom” advocates, limited the FDA’s pre‑market control over supplements; libertarian politicians like Ron Paul and figures such as Prince/King Charles support aspects of this agenda. More recently, anti‑vaccination activism, opposition to the Affordable Care Act, and then COVID‑19 mandates and vaccines gave the HFM a major boost and re-grouped as “medical freedom” or “health freedom” across partisan lines, but with a strong right‑wing infrastructure.

The HFM’s main players include politicians (e.g. Ron Paul, Tom Harkin, Orrin Hatch, Robert F. Kennedy Jr.) and media personalities (e.g. Gary Null, Kevin Trudeau, and many supplement‑selling influencers as well as SCAM doctors). Many of them have strong financial ties to supplement, wellness, or SCAM industry.

The HFM’s stated aims sound liberal: individual autonomy, informed and access to SCAM. In practice, however, its core goals are sharper and consistently deregulatory:

  • Limit or abolish pre‑market safety and efficacy requirements for supplements and many SCAMs.
  • Oppose or roll back mandatory childhood vaccination, COVID‑19 vaccination and mask rules, school-entry requirements, and sometimes even basic disease‑reporting obligations.
  • Resist overarching government health programs, including water fluoridation, electronic health records, and population‑level data sharing, which they portray as surveillance or tyranny.
  • Create broad legal shields for all types of SCAM practitioners and restrict the enforcement powers of medical boards and public‑health authorities.

While the rhetoric centres on “freedom” and “choice”, the policy is liberating commercial interests from evidence‑based standards and oversight. For this, the HFM uses a mixture of advocacy and classic populist agitation:

  • Legislative lobbying: Drafting model bills that redefine or exempt SCAM practitioners, weaken vaccination requirements, and restrict state health departments’ emergency powers.
  • Litigation: Groups such as the “Health Freedom Defense Fund” use lawsuits against mask mandates, vaccine requirements, and school or airline rules both as legal tools and as high‑visibility fundraising and mobilization devices.
  • Electoral politics: Endorsing and funding candidates who promise to “reign in” public‑health agencies, defund WHO, or defy CDC guidance; in some places, anti‑vaccine activists have captured local hospital or school boards.
  • Media ecosystems: Conferences, podcasts, Substack newsletters, and “documentaries” circulate narratives of regulatory capture, big‑pharma malfeasance, and heroic mavericks, often entwined with sales of supplements or courses.

These activities reinforce distrust of science and conventional medicine and thus create a host of issues and problems:

  • Selective use of autonomy: Autonomy is invoked vigorously when opposing vaccines, fluoridation, or regulation of supplements, but tend to disregard it when patients are misled by misinformation, coercive marketing, or opaque conflicts of interest in the alternative sector itself. Yet protection against deception and unsafe products is essential for meaningful autonomy; “choice” among misrepresented options is not genuine choice.
  • Systematic downplaying of risk and evidence: The HFM treats lack of evidence of benefit as if it were evidence of safety and legitimacy and often dismisses adverse‑event data. Regulators and critics must meet impossibly high standards, while proponents of SCAM face essentially none.
  • Commercial conflicts of interest: Many leading voices within the HFM derive substantial income from selling SCAM. The HFM criticizes “Big Pharma” conflicts of interest while largely ignoring or concealing its own.
  • Wilful ignorance of collective harms: Opposition to vaccination, masking, and quarantine treats infections as purely individual matters, neglecting that infectious disease risk is shared and that one person’s “choice” can impose morbidity and mortality on others. Yet any rights framework that leaves no space for legitimate public‑health constraints on individual choice is incompatible with controlling epidemics.
  • Alliance with broader conspiracist and extremist currents: Sections of the HFM have fused with anti‑globalist, anti‑UN/WHO, and sometimes far‑right political currents, amplifying conspiracy narratives and distrust that spill over into many domains beyond health. Thus they corrode trust in institutions that are necessary for coordinating large‑scale health responses.

In a nutshell, the HFM is a deregulatory, commercially entangled project that uses the language of liberty to erode evidence‑based medicine and to normalise quackery as well as anti‑vaccination politics. To put it bluntly: the HFM does not seem to operate in the best interest of either the individual patient or the collective public health.

Insomnia is a prevalent disorder that is associated with substantial impairment. Homeopathy has been proposed as a complementary treatment for insomnia, but its clinical effects remain uncertain.

This systematic review assessed the efficacy, effectiveness, and safety of homeopathic treatments for insomnia. Prospective comparative studies evaluating any homeopathic preparation for insomnia were included. Searches in MEDLINE, EMBASE, seven additional databases, and three trial registries were conducted through August 2025. Risk of bias, intervention complexity, model validity, and pragmatism were assessed using respectively RoB 2, ROBINS-I, iCAT, MVHT, and RITES. Data were synthesized using random-effects meta-analyses, and certainty of evidence was evaluated using GRADE.

Eight randomized controlled trials (RCTs; n = 364 participants) and four non-randomized studies (NRSIs; n = 517) met the inclusion criteria. In adults, sleep quality (MD = −2.6 points; 95% CI −5.5 to 2.6; low certainty) and insomnia severity (MD = −3.2; 95% CI −5.68 to −0.72, moderate certainty) were reported in one RCT each. For total sleep time, the pooled MD of three RCTs was 0.65 hours (95% CI −0.9 to 2.2; low certainty). In children, one open-label RCT suggested a difference in insomnia severity, but certainty of evidence was very low. Adverse events were rarely reported, resulting in low certainty evidence.

The authors concluded that the current evidence is mainly limited by imprecision and risk of bias. The available evidence does not allow firm conclusions regarding the effects of homeopathy for insomnia. High-quality, replicated trials with systematic adverse event monitoring are needed.

15 years ago, I published a similar review entitled “Homeopathy for insomnia and sleep-related disorders: a systematic review of randomised controlled trials” (Focus on Alternative and Complementary Therapies Volume 16(3) September 2011 195–199)). Here is its abstract:

The aim of this review was the critical evaluation of evidence for the effectiveness of homeopathy for insomnia and sleep-related disorders. A search of MEDLINE, AMED, CINAHL, EMBASE and Cochrane Central Register was conducted to find RCTs using any form of homeopathy for the treatment of insomnia or sleep-related disorders. Data were extracted according to predefined criteria; risk of bias was assessed using Cochrane criteria. Six randomised, placebo-controlled trials met the inclusion criteria. Two studies used individualised homeopathy, and four used standardised homeopathic treatment. All studies had significant flaws; small sample size was the most prevalent limitation. The results of one study suggested that homeopathic remedies were superior to placebo; however, five trials found no significant differences between homeopathy and placebo for any of the main outcomes. Evidence from RCTs does not show homeopathy to be an effective treatment for insomnia and sleep-related disorders.

The findings of the two reviews are remarkably similar. For the following reasons, I find this notable:

  • One would have hoped that 15 years are a long enough time for clarifying the issue, particularly as insomnia is not an unimportant condition for homeopathy.
  • The new review is authored by well-known proponents. It seems unexpected that they (almost) go as far as admitting that the evidence for homeopathy as a treatment for insomnia is not positive.
  • We have here, I think, a textbook example of how proponents of homeopathy prettify results that do not confirm their belief.

SO FAR, SO GOOD.

But now consider this: There are two further reviews of the same subject!

The first is entitled “Homoeopathy for insomnia: A meta-analysis of clinical evidence – Journal of Integrated Standardized Homoeopathy“. Here is its abstract:

Objectives: Insomnia is a prevalent sleep disorder characterised by challenges in initiating, maintaining or achieving restorative sleep, resulting in compromised daytime functionality. Traditional therapeutic modalities frequently encompass pharmacological treatments, which may have adverse effects and potential for dependency. Numerous patients pursue alternative methodologies, such as homoeopathy, which is attributed to its personalised, holistic and non-invasive treatment framework. This thorough examination assesses the effectiveness of homoeopathy in promoting better sleep quality and overall wellness in people with insomnia by analysing randomised controlled trials (RCTs).

Material and Methods: This meta-analysis sought to ascertain whether homoeopathy induces a statistically significant enhancement in the management of insomnia, concentrating on aspects of sleep quality, duration and general well-being. All RCTs addressing insomnia treated with homoeopathic interventions were included in this review. All studies were meticulously documented in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Three evaluators independently reviewed and compiled the literature, extracting comprehensive details regarding participants, study designs, therapeutic interventions and follow-up pertaining to homoeopathic treatment. The primary outcome of the investigation was disease assessment based on sleep diary scores, with an additional outcome being the enhancement of quality of life.

Results: The analysis revealed that homoeopathic remedies exhibited statistically significant improvement over placebo in the management of insomnia. The overall pooled effect size, standardised mean difference (random), was −0.60, standard error (random) was 0.42 and confidence interval (random) at 95% ranged from −0.93 to −0.26. The risk of bias was assessed for all studies.

Conclusion: This meta-analysis shows that homoeopathic remedies are effective in treating insomnia, but more studies are required for accuracy.

The last review is entitled “Effectiveness of Homeopathic Interventions for Insomnia and Sleep Disorders: A Systematic Review and Meta-Analysis“. Here is its abstract:

Insomnia is a common sleep disorder, and many individuals seek alternative treatments like homeopathy. However, evidence for its effectiveness remains controversial. This systematic review and meta-analysis evaluated the effectiveness of homeopathic interventions for insomnia and sleep-wake disorders. A comprehensive search of PubMed, MEDLINE, CINAHL, and the Cochrane Library was conducted for studies published between 2010 and 2025. We included randomized controlled trials (RCTs) and non-randomized studies involving adults (≥18 years) with primary insomnia receiving any homeopathic intervention compared to placebo, no treatment, or active care. Primary outcomes included validated sleep quality measures (e.g., Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI). Four reviewers independently performed study selection, data extraction, and risk of bias assessment using RoB 2.0 and ROBINS-I. A random-effects meta-analysis was conducted for controlled trials, and a narrative synthesis for non-randomized studies. Certainty of evidence was assessed using Grading of Recommendations, Assessment, Development and Evaluation (GRADE). The search yielded 1304 records; 12 studies (nine RCTs and three non-randomized) met inclusion criteria. Meta-analysis showed a large, statistically significant positive effect of homeopathy on sleep outcomes (SMD = 0.81, 95% CI [0.24, 1.38], p = 0.0055), with substantial heterogeneity (I² = 86.04%) and publication bias (Egger’s test, p = 0.0079). Most studies had high or critical risk of bias, and overall certainty was low. Homeopathic interventions showed a large positive effect on sleep outcomes, but due to high bias, heterogeneity, and publication bias, evidence remains low-certainty and insufficient to support effectiveness. High-quality RCTs are needed.

What should we make of this?

We now have two reviews concluding that there is no good evidence and two implying that homeopathy is effective for insomnia! This clearly demonstrates how easy it is to mislead the public with seemingly rigorous reviews.

I must say, I pity all the interested lay people who are trying to make sense of this mess.

How can they arrive at the best available, most reliable evidence?

We have here, I think, another textbook example; one of how important it is to run reality checks. But surely, we cannot possible ask of a lay person to understand why the last two reviews are badly misleading. What we need is an accessible tool for differentiating the science from the pseudoscience, the reliable from the unreliable.

Unfortunately, such a tool does not exist. But there are a few indicators:

  • Is the journal that published the review reputable?
  • Are the authors affiliated to reputable institutions?
  • Do the authors have a history of critical analysis or one of uncritical promotion?
  • Do they explain clearly and provide the essential details of their work?

These are issues that lay people might be able to check relatively easily. The above 4 reviews demonstrate that using them does not always provided an entirely clear cut-off. However, it might give some valuable pointers into the right direction.

Dame Shirley Porter died on May 2. She passed away in Herzliya, Israel, where she had spent much of her time since the early 2000s. Dame Shirley had been the former leader of Westminster City Council and a dominant figure in 1980s UK municipal politics. Once hailed as the “Iron Lady of the town halls,” her career was ultimately defined by the “homes for votes” scandal, which led to her being labeled by the district auditor as the “most corrupt” politician of her era.

The daughter of Tesco founder Sir Jack Cohen, Porter used her wealth to influence both politics and public policy. Beyond the well-documented legal battles over her misuse of council powers – which eventually saw her pay a £12.3m settlement in 2004 – Porter was a prolific, if often controversial, philanthropist. Notably, she was the primary financial backer of the Smallwood Report (2005). Entitled The Role of Complementary and Alternative Medicine in the NHS, the report was commissioned by the then Prince of Wales and written by economist Christopher Smallwood. The study was heavily criticized by myself and several others for advocating that so-called alternative medicine (SCAM) to be funded by the UK taxpayer. The editor of The Lancet, dismissed the findings as “dangerous nonsense” and I suggested the report’s pro-SCAM conclusions were written befor anyone had even looked at the evidence.

Dame Shirely was also a trustee of the London Institute for Mathematical Sciences and as a co-founder of the Porter Foundation. Through these organizations, she funded major capital projects including the Porter School of Environmental Studies at Tel Aviv University and various galleries at the V&A and the National Portrait Gallery.

She is survived by her daughter, Linda.

Recent statements concerning US pharmaceutical pricing have drawn renewed attention to an entirely new horizon in mathematics. The method, associated with remarks by Donald Trump and repeated by several of his sycophants, departs from standard arithmetic in a manner that is rhetorically vigorous but mathematically ridiculous.

Percentage change is defined relative to a single, clearly specified baseline. A decrease from $600 to $100 is therefore calculated as (600-100)/600×100 = 83.3%. In other words, the price falls by 83.3% relative to the original $600 price. This is the method used in economics, finance, accounting, retail pricing, and presumably even by the secondary-school mathematics teachers who attempted to educate Trump.

However, the new alternative math proceeds differently. It implicitly combines two distinct operations: first, the increase from $100 to $600, correctly described as a 500% rise when measured against the initial $100; and second, the subsequent decrease from $600 back to $100. Rather than evaluating this decrease against the higher price, however, the method appears to retain the earlier, lower baseline, thereby generating a claim of a “600% saving.” The arithmetic equivalent of moving the goalposts and then declaring victory by an even larger margin.

Within standard mathematics, this shift in baseline is not permissible. Percentage changes are inherently asymmetric because they depend entirely on the reference point selected. The same absolute difference – in this case, $500 –  produces different percentage values depending on whether it is measured relative to $100 or $600. This is not a technical loophole but the entire point of percentages.

The problem with this approach becomes clearer if one follows it to its logical conclusion. Under standard arithmetic, a 100% price reduction means the price has fallen all the way to zero: a $100 product reduced by 100% costs nothing. A reduction greater than 100% would therefore produce a negative price, meaning the seller would have to pay the customer to accept the product. If one claims that a fall from $600 to $100 represents a 600% decrease, the numbers cease to correspond to any coherent pricing system. The calculation implies that prices can fall not merely to zero, but to values several times smaller than zero.

The attraction of the Trump method is easy to understand. By selecting whichever baseline produces the largest possible percentage, the resulting figure acquires an air of spectacular achievement. It transforms an already substantial price reduction into something approaching numerical performance art.

Trump’s alternative arithmetic therefore succeeds in generating impressively large numbers by abandoning the one feature percentages require most: consistency. The result is as unsound as most things about Trump. Yet it seems rhetorically effective – particularly with “low IQ people”, as Trump likes to call his followers.

In other words, by cherry-picking the baseline for maximum impact, the Trump method turns an already solid 83% cut into a sensational “600% savings”. It sacrifices precision for hype – effective populism perhaps, poor math for sure!

None of this would be worth mentioning, of course, if it were the only incident where Trump misleads his public. Sadly, he is telling multiple and often much more consequential untruths on a daily basis.

I am quite fond of garlic, but not as a cancer therapy. Dr. Mohsen Ali, a former doctor whose UK medical license was revoked by the General Medical Council (GMC) in January 2015, has been permanently struck off the medical register following a Medical Practitioners Tribunal Service (MPTS) investigation into his running of an illegal clinic. The tribunal, which began proceedings on December 1, 2025, reconvened on January 14 and concluded from April 22 to 24, 2026, found Ali guilty of serious professional misconduct for preying on vulnerable cancer patients with unproven and dangerous treatments.

In 2018, Ali treated two patients from a semi-detached Leicester property described as a “squalid council house.” Patient A had stage three prostate cancer, while Patient B suffered from terminal ovarian cancer. Referred to Ali by word-of-mouth, both were told he could cure their cancers with a claimed 90% success rate. He charged Patient A up to £15,000 and Patient B between £10,000 and £12,000 for sessions involving intravenous vitamin C, garlic oil, ozone therapy, oxygenated water, and sodium bicarbonate injections.

Ali disparaged conventional medicine, asserting that the NHS was “killing them” through ineffective chemotherapy and radiotherapy, while “big pharma companies were making money.” During a phone call, he laughed off Patient A’s diagnosis, calling prostate cancer “easy to cure.” For Patient B, he overrode the NHS’s prognosis that nothing more could be done, promising her husband a full recovery. Patient B died shortly after stopping treatment, before police and Public Health England (PHE) probes began.

The case surfaced when Patient A emailed Leicestershire Police, prompting a GMC referral. A police raid uncovered a flyer at Ali’s address, advertising him as a “qualified doctor” who left the NHS because standard treatments “did not work.” It invoked “Allah the best healer” and boasted over 90% cure rates for cancers and other severe illnesses.

MPTS evidence revealed grave hygiene failures. PHE inspections described the property as a “dirty and unhygienic” shared residential-clinical space with visibly contaminated surfaces, reused equipment without decontamination, and no basic infection prevention measures. Ali reused intravenous bags, exposing patients to serious infection risks. The tribunal deemed his actions dishonest, as he knew these were not evidence-based cancer cures.

An expert witness confirmed no clinical studies support these so-called alternative medicines (SCAMs) for curing any cancer. Ali also failed to obtain informed consent, particularly from Patient B. Absent from the hearing, he emailed the GMC denying claims of cure, but the flyer and patient testimonies contradicted him.

Ali, who graduated from Cairo University in 1994 and practiced in the UK from 2001 was erased him from the register, underscoring the dangers of unqualified SCAM practitioners – even (or perhaps especially) when they have a doctor title.

Trump’s anti-science stance is well-known. What we did not know is how far he might venture in this direction. On Friday, April 24, 2026, the Trump administration took the unprecedented step of firing all sitting members of the National Science Board (NSB). This body acts as the governing board for the National Science Foundation (NSF) and serves as an independent advisory arm to the President and Congress on matters of national science policy.

While Trump does have the legal authority to appoint these members, they are historically granted staggered, six-year terms to ensure the board remains a non-partisan anchor for US research. The mass termination via email happened without a stated cause or immediate replacement plan. Trump’s action has raised significant concerns regarding the future of independent scientific funding and oversight in the United States.

The terminated members include:

  • Dan Reed (Chair): A computer scientist and former Microsoft executive with deep expertise in high-performance computing and “big data” infrastructure.
  • Victor R. McCrary (Vice Chair): A physical chemist and research VP at the University of the District of Columbia; highly regarded for his work in technology transfer and innovation.
  • Willie E. May: The former Director of NIST and a leading expert in metrology (the science of measurement) and chemical standards.
  • Arati Prabhakar: An applied physicist and former Director of DARPA; she is a specialist in transitioning high-risk research into commercial technologies.
  • Dario Gil: Senior VP at IBM and Director of IBM Research; a global authority on quantum computing and the ethics of Artificial Intelligence.
  • Keivan Stassun: An astrophysicist at Vanderbilt University known for his research on exoplanets and his efforts to increase diversity in the physical sciences.
  • Julia Phillips: A materials scientist and retired VP of Sandia National Laboratories; an expert in thin-film research and a member of the National Academy of Engineering.
  • Roger Beachy: A biologist and pioneer in plant biotechnology; he was instrumental in developing the first genetically modified food crops (virus-resistant tomatoes).
  • Marvi Matos Rodriguez: An aerospace engineer and executive specializing in fusion energy and advanced material systems for the energy sector.
  • Sudarshan S. Babu: An engineering professor at the University of Tennessee/Oak Ridge National Laboratory; a top expert in advanced 3D printing and manufacturing.
  • Aaron Dominguez: An experimental particle physicist and Provost at Catholic University of America who contributed to the Higgs boson discovery at CERN.
  • Melvyn Huff: A mathematician and educator focused on the development of rigorous mathematics curricula and analytical modelling.

As the head of the Executive Branch, the President has the right to remove any official who is not explicitly protected by “for cause” language, ensuring the agency follows the administration’s policy goals. Nonetheless, this is a “norm-breaking” action that ignores the statutory design of staggered terms. It effectively turns an independent advisory body into a political one, which most likely will lead to legal challenges regarding the “independence” of the NSF.

Because the White House has failed to issue an official statement justifying the dismissals, the reason for this spectacular action remains speculative. Considering recent tensions between the administration and the board, as well as broader policy shifts, the dismissals are seen not primarily as a targeted attack on science itself, but more as a systematic effort to remove independent oversight and “unelected experts” who might challenge the Executive Branch’s policy directives.

The conclusion, I fear, is this:

in the US, democracy is now in its dying days.

The defence of anthroposophical medicine – or of any other unproven modality – as articulated, for example, by figures like Weleda CEO Tina Müller, presents a vision of patient-centred care and economic pragmatism. However, when held against the light of current clinical standards and the principles of evidence-based medicine (EBM), it reveals significant cracks.

The most profound problem lies in the definition of scientific evidence. Proponents often point to decades of “positive experience” and high patient satisfaction as proof of effectiveness. Yet, in the hierarchy of science, anecdotal success sits at the very bottom. Anthroposophical treatments lack biological plausibility. Their perceived benefits are largely indistinguishable from context effects (such as placebo). Anthroposophical medicine might provide more time, empathy, and personal attention – factors that undoubtedly improve a patient’s well-being but do not validate the effectiveness of the specific remedies used. When independent bodies subject these treatments to rigorous, high-quality trials, the purported effects usually vanishe.

Anthroposophical medicine represents merely a tiny percentage of our healthcare expenditures. Therefore, proponents argue, little money would be saved by getting rid of it. This argument is a calculated distraction from the ethical core of the issue. While the fiscal burden may be marginal, the scientific cost is immense. A statutory health insurance system is built on a social contract of solidarity; it functions under the premise that public funds are reserved for treatments of proven value and effectiveness. To fund therapies that lack plausibility as well as reproducible results is to erode the credibility of medicine and rational thought. It is not a question of the amount of money, but the principle of integrity: every Euro, £ and $ spent on unproven treatments is a euro, £, and $ diverted from underfunded and often life-saving healthcare.

The regularly made appeal to the Swiss Model as a beacon of success also requires a more critical reading. The integration of so-called alternative medicine (SCAM) in Switzerland was, at its heart, a result of direct democracy rather than evidence. While the Swiss public voted for inclusion, the majority of the medical community remains deeply sceptical. To cite Switzerland as “proof” that anthroposophical medicine has fulfilled the criteria of EBM is to conflate political popularity with scientific validation. Democracy can decide how a nation spends its money, but it cannot vote a reliable evidence-base into existence.

Finally, we must consider the human risk of legitimizing non-evidenced-based practices. When a state-sanctioned insurance system places such therapies on the same pedestal as EBM, it risks misleading vulnerable individuals. For patients facing chronic or life-threatening illnesses, the “integrative” path can lead to a dangerous delay in seeking conventional, life-saving interventions. By treating subjective belief and peer-reviewed science as equal peers, we risk entering a “post-truth” medical era where the desire for a “natural” or “holistic” experience outweighs the necessity for proof.

In conclusion, while the call for a more “human” and “holistic” medical system might be noble, it must not come at the expense of scientific rigor. It is deeply misleading to imply that this is an ‘either or’; good medicine will always be based on both. A healthcare system that prioritizes popularity over proof risks becoming a system of expensive comfort rather than one of effective healing. True patient appreciation lies not in offering unproven choices, but in ensuring that every treatment covered by the public purse is supported by sound evidence. Not following this strategy is a disservice to patients and to progress.

So, the next time you hear people defending anthroposophical medicine or any other unproven modality, please look behind the smoke screen and find out why they do it. More often than not, you will then identify a massive conflict of interest. My advice is to listen to independent experts and to dismiss the people with an axe to grind.

This three-month, double-blind, randomized (1:1), placebo-controlled trial evaluated whether individualized homeopathic medicinal products (IHMPs) are superior to placebo in reducing anorectal symptom severity and improving quality of life over 3 months in adults with hemorrhoids, and to assess their safety and tolerability.
A total of 134 adults with grade I–III hemorrhoids received either:
  • IHMPs (verum; n = 67),
  • or identical-looking placebos (control; n = 67)

Both treatments were administered alongside standard concomitant care including sitz baths, pelvic floor exercises, and dietary advice.

The primary outcome was the change in the Anorectal Symptom Severity and Quality-of-Life (ARSSQoL) total score over 3 months. Secondary outcomes included ARSSQoL subscales, numeric rating scales (NRSs), and EQ-5D-5L questionnaire and visual analog scale. Outcomes were assessed monthly for up to 3 months. The primary analysis compared model-based estimates of change over time between groups using repeated measures analysis of variance; the secondary analyses comprised multivariate linear mixed models, Bayesian hierarchical modeling, and sensitivity analyses under intention-to-treat and per-protocol frameworks.
After 3 months, IHMPs demonstrated significantly greater improvement than placebo in ARSSQoL total (mean group difference −6.5, 95% confidence interval −8.7, −4.2; p < 0.001), with large effect sizes. Most ARSSQoL subscales, NRSs, and EQ-5D-5L scores favored IHMPs. Multivariate and Bayesian analyses confirmed consistent intervention-by-time effects, with a high probability of directional superiority for IHMPs in symptom reduction and self-rated health, while sensitivity analyses showed the findings to be robust to protocol deviations. Kent’s repertory was the most frequently used in remedy selection. Nitricum acidum emerged as the most effective remedy. No treatment-related serious adverse events were observed.
The authors concluded that, in this randomized, double-blind trial, IHMPs were associated with greater reductions in the ARSSQoL improvements in quality of life compared with placebo over 3 months. Although the magnitude and consistency of effects across multiple analytic approaches suggest potential clinical relevance, the absence of a validated minimal clinically important difference for the ARSSQoL warrants cautious interpretation. Further independent replications and methodological refinement of outcome thresholds are needed.
I must admit that I am puzzled. Homeopathic treatment of hemorhoids would normally require giving a remedy that, in a healthy person, causes the symptoms of this condition. This, however, is not the case for any of the administered remedies. Homeopaths might counter that a form of homeopathy was used called ‘clinical homeopathy’ where one prescribes remedies according to the condition, Arnica for cuts and bruises, for instance. But this is not ‘individualised homeopathy’ which the authors claimed to have used and where the remedies are prescribed not according to the disease but according to the individual’s symptoms and type.
So, what is going on here?
In my search for an answer, I looked at the authors affiliations:
  • Department of Repertory, D. N. De Homoeopathic Medical College and Hospital, Government of West Bengal, Kolkata, India.
  • East Bishnupur State Homoeopathic Dispensary, Chandi Daulatabad Block Primary Health Centre, under Department of Health & Family Welfare, Government of West Bengal, Parganas, India.
  • Department of Pathology & Microbiology, D. N. De Homoeopathic Medical College and Hospital, Government of West Bengal, Kolkata, India.
  • Department of Organon of Medicine and Homoeopathic Philosophy, D. N. De Homoeopathic Medical College and Hospital, Government of West Bengal, Kolkata, India.
  • Department of Materia Medica, D. N. De Homoeopathic Medical College and Hospital, Government of West Bengal, Kolkata, India.
  • Department of Organon of Medicine and Homoeopathic Philosophy, National Institute of Homoeopathy, Ministry of AYUSH, Government of India, Salt Lake, Kolkata, India.
  • Department of Community Medicine, D. N. De Homoeopathic Medical College and Hospital, Government of West Bengal, Tangra, India.

This list does not inspire me with confidence that this study is reliable.

Next I looked around for further trials of homeopathy for hemorrhoids – and I found another study by the same authors published 2 years earlier in the same dodgy journal:

Objectives: To investigate the efficacy and safety of individualized homeopathic medicines (IHMs) in treating hemorrhoids compared with placebo. Design: This is a double-blind, randomized (1:1), two parallel arms, placebo-controlled trial. Setting: The trial was conducted at the surgery outpatient department of the State National Homoeopathic Medical College and Hospital, Lucknow, Uttar Pradesh, India. Subjects: Patients were 140 women and men, aged between 18 and 65 years, with a diagnosis of primary hemorrhoids grades I-III for at least 3 months. Excluded were the patients with grade IV hemorrhoids, anal fissure, and fistula, hypertrophic anal papillae, inflammatory bowel disease, coagulation disorders, rectal malignancies, obstructed portal circulation, patients requiring immediate surgical intervention, and vulnerable samples. Interventions: Patients were randomized to Group 1 (n = 70; IHMs plus concomitant care; verum) and Group 2 (n = 70; placebos plus concomitant care; control). Outcome measures: Primary-the anorectal symptom severity and quality-of-life (ARSSQoL) questionnaire, and secondary-the EuroQol 5-dimensions 5-levels (EQ-5D-5L) questionnaire and EQ visual analogue scale (VAS); all of them were measured at baseline, and every month, up to 3 months. Results: Out of the 140 randomized patients, 122 were protocol compliant. Intention-to-treat sample (n = 140) was analyzed. The level of significance was set at p < 0.05 two tailed. Statistically significant between-group differences were elicited in the ARSSQoL total (Mann-Whitney U [MWU]: 1227.0, p < 0.001) and EQ-5D-5L VAS (MWU: 1228.0, p = 0.001) favoring homeopathy against placebos. Sulfur was the most frequently prescribed medicine. No harm or serious adverse events were reported from either of the groups. Conclusions: IHMs demonstrated superior results over placebo in the short-term treatment of hemorrhoids of grades I-III. The findings are promising, but need to be substantiated by further phase 3 trials.

Are we to believe that the authors were able to pull off 2 large almost identical studies within just 2 years?

Pull the other one!

Subscribe via email

Enter your email address to receive notifications of new blog posts by email.

Recent Comments

Note that comments can be edited for up to five minutes after they are first submitted but you must tick the box: “Save my name, email, and website in this browser for the next time I comment.”

The most recent comments from all posts can be seen here.

Archives
Categories